Skip to main content

and
  1. Article

    Open Access

    Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany—results from a national survey

    Radiation oncology is a pivotal modality in the treatment of hematologic malignancies. To enable state-of-the-art patient care, structured education during residency is essential. However, given the lack of de...

    Stephan Rehn, Michael Oertel, Philipp Linde in Strahlentherapie und Onkologie (2024)

  2. Article

    Open Access

    Radiation dose is associated with improved local control for large, but not small, hepatocellular carcinomas

    With advances in understanding liver tolerance, conformal techniques, image guidance, and motion management, dose-escalated radiotherapy has become a potential treatment for inoperable hepatocellular carcinoma...

    Uri Amit, Jahan J Mohiuddin, Andrzej P Wojcieszynski, Joanna Harton in Radiation Oncology (2023)

  3. Article

    Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report

    The role of radiation therapy (RT) varies across hematologic malignancies (HM). Radiation oncology (RO) resident comfort with specific aspects of HM patient management is unknown. The International Lymphoma RO...

    Jenna M. Kahn, Joanna C. Yang, Joachim Yahalom in Journal of Cancer Education (2023)

  4. No Access

    Article

    Tolerability of sequential immune therapy and palliative radiotherapy to the cervical and thoracic spine

    Use of immune therapy in metastatic cancers is rapidly expanding; however, its combination with commonly prescribed palliative radiation fields and doses is not well studied. To investigate this, we evaluated ...

    W. Tristram Arscott, Abigail Doucette, Pallavi Kumar in Journal of Radiation Oncology (2018)

  5. No Access

    Article

    A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer

    Patients with locally advanced pancreatic cancer typically have poor outcomes, with a median survival of approximately 16 months. Novel methods to improve outcomes are needed. Nab-paclitaxel (Abraxane) has sho...

    Jacob E. Shabason, Jerry Chen in Cancer Chemotherapy and Pharmacology (2018)

  6. No Access

    Chapter

    Lower Gastrointestinal Malignancies

    Lower GI cancers present a particular problem for multidisciplinary care. Concurrent chemoradiotherapy is the standard of care, but with it comes a host of treatment-related toxicities. For rectal cancer, preo...

    John P. Plastaras, Stefan Both, Haibo Lin in Target Volume Delineation and Treatment Pl… (2018)

  7. No Access

    Chapter

    Mediastinal Lymphoma

    Hodgkin lymphoma and primary mediastinal large B cell lymphoma (a form of non-Hodgkin lymphoma) are lymphomas that commonly involve the mediastinum and typically affect adolescents and young adults. Owing to t...

    Bradford S. Hoppe, Stella Flampouri in Target Volume Delineation and Treatment Pl… (2018)

  8. No Access

    Article

    Radiation Oncology: a Primer for Medical Students

    Radiation oncology requires a complex understanding of cancer biology, radiation physics, and clinical care. This paper equips the medical student to understand the fundamentals of radiation oncology, first wi...

    Abigail T. Berman, John P. Plastaras, Neha Vapiwala in Journal of Cancer Education (2013)

  9. No Access

    Article

    Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer

    Platinum compounds or bevacizumab, in combination with gemcitabine, achieved good response rates in early studies in advanced pancreatic cancer. This prompted an evaluation of an aggressive approach to allow b...

    Davendra P. S. Sohal, James M. Metz, Wei**g Sun in Cancer Chemotherapy and Pharmacology (2013)

  10. No Access

    Article

    Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients

    The role of adjuvant radiotherapy (RT) for pancreatic cancer remains controversial despite the completion of three multi-institutional randomized trials. This study examines the survival impact of postoperativ...

    John S. Moody, Stephen M. Sawrie, Kevin R. Kozak in Journal of Gastroenterology (2009)

  11. No Access

    Article

    Stage-Specific Survival Differences Associated with Postoperative Radiotherapy for Gastrointestinal Cancers

    To study the frequency and effect associated with postoperative radiotherapy (RT) for patients with resected gastrointestinal (GI) cancers.

    John S. Moody, Stephen M. Sawrie, Kevin R. Kozak in Journal of Gastrointestinal Cancer (2008)